These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29966975)
1. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc. Qu H; Liu H; Jin Y; Cui Z; Han G Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975 [TBL] [Abstract][Full Text] [Related]
2. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc. Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175 [TBL] [Abstract][Full Text] [Related]
3. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma. Bonazzoli E; Bellone S; Zammataro L; Gnutti B; Guglielmi A; Pelligra S; Nagarkatti N; Manara P; Tymon-Rosario J; Zeybek B; Altwerger G; Menderes G; Han C; Ratner E; Silasi DA; Huang GS; Andikyan V; Azodi M; Schwartz PE; Santin AD Gynecol Oncol; 2020 Sep; 158(3):769-775. PubMed ID: 32600791 [TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression. Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447 [TBL] [Abstract][Full Text] [Related]
5. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway. Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998 [TBL] [Abstract][Full Text] [Related]
6. Tumour suppressive function of HUWE1 in thyroid cancer. Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z J Biosci; 2016 Sep; 41(3):395-405. PubMed ID: 27581931 [TBL] [Abstract][Full Text] [Related]
7. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARα pathway in Chinese individuals. Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064 [TBL] [Abstract][Full Text] [Related]
8. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Kim J; Roh M; Abdulkadir SA BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470 [TBL] [Abstract][Full Text] [Related]
9. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma. Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091 [TBL] [Abstract][Full Text] [Related]
10. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival. Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298 [TBL] [Abstract][Full Text] [Related]
11. Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models. Kunz V; Bommert KS; Kruk J; Schwinning D; Chatterjee M; Stühmer T; Bargou R; Bommert K Sci Rep; 2020 Oct; 10(1):18419. PubMed ID: 33116152 [TBL] [Abstract][Full Text] [Related]
12. The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor. Cancer Discov; 2013 Jul; 3(7):OF32. PubMed ID: 23847377 [TBL] [Abstract][Full Text] [Related]
13. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1. Li D; Zhang Z Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902 [TBL] [Abstract][Full Text] [Related]
14. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion. He Y; Zhou J; Wan Q Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091 [TBL] [Abstract][Full Text] [Related]
15. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Zhao X; D' Arca D; Lim WK; Brahmachary M; Carro MS; Ludwig T; Cardo CC; Guillemot F; Aldape K; Califano A; Iavarone A; Lasorella A Dev Cell; 2009 Aug; 17(2):210-21. PubMed ID: 19686682 [TBL] [Abstract][Full Text] [Related]
17. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer. Zhang F; Wu Z Biochimie; 2017 Sep; 140():66-72. PubMed ID: 28624527 [TBL] [Abstract][Full Text] [Related]
18. ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells. Lee J; Kim J; Shin J; Kang Y; Choi J; Cheong H Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502089 [TBL] [Abstract][Full Text] [Related]
19. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Zhao X; Heng JI; Guardavaccaro D; Jiang R; Pagano M; Guillemot F; Iavarone A; Lasorella A Nat Cell Biol; 2008 Jun; 10(6):643-53. PubMed ID: 18488021 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7. Hong Z; Fu W; Wang Q; Zeng Y; Qi L Biomed Pharmacother; 2019 Jun; 114():108822. PubMed ID: 30951946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]